参考文献/References:
[1] 官宝怡,赵福海. 高密度脂蛋白胆固醇与心血管风险研究进展[J]. 心血管病学进展, 2019, 40(3):317-320.
[2] Qian H,Zhao X,Cao P,et al. Structure of the human lipid exporter ABCA1[J]. Cell,2017,169(7):1228-1239.e10.
[3] Dean M,Rzhetsky A,Allikmets R. The human ATP-binding cassette(ABC) transporter superfamily[J]. Genome Res,2001,11(7):1156-1166.
[4] 韩耀霞,张强,梁斌,等. ABCA1在冠心病及其发病机制中的研究新进展[J]. 中国动脉硬化杂志,2015,23(4):417-421.
[5] Biemans-Oldehinkel E,Doeven MK,Poolman B. ABC transporter architecture and regulatory roles of accessory domains[J]. FEBS Lett,2006,580(4):1023-1035.
[6] Ordovas JM. ABC1:the gene for Tangier disease and beyond[J]. Nutr Rev,2000,58(3 Pt 1):76-79.
[7] Oram JF,Heinecke JW. ATP-binding cassette transporter A1:a cell cholesterol exporter that protects against cardiovascular disease[J]. Physiol Rev,2005,85(4):1343-1372.
[8] Shen W,Anwaier G,Cao Y,et al. Atheroprotective mechanisms of tilianin by inhibiting inflammation through down-regulating NF- kB pathway and foam cells formation[J]. Front Physiol,2019,10:825.
[9] Ou X,Gao JH,He LH,et al. Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response[J]. Biochim Biophys Acta Mol Cell Biol Lipids,2020,1865(2):158535.
[10] Zhang CJ,Zhu N,Liu Z,et al. Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis[J]. Biochim Biophys Acta Mol Cell Biol Lipids,2020,1865(2):158547.
[11] Wacker BK,Dronadula N,Bi L,et al. Apo A-I(apolipoprotein A-I) vascular gene therapy provides durable protection against atherosclerosis in hyperlipidemic rabbits[J]. Arterioscler Thromb Vasc Biol,2018,38(1):206-217.
[12] Wacker BK,Dronadula N,Zhang J,et al. Local vascular gene therapy with apolipoprotein A-I to promote regression of atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2017,37(2):316-327.
[13] Vaisman BL,Demosky SJ,Stonik JA,et al. Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis[J]. J Lipid Res,2012,53(1):158-167.
[14] Stamatikos A,Dronadula N,Ng P,et al. ABCA1 overexpression in endothelial cells in vitro enhances apoAI-mediated cholesterol efflux and decreases inflammation[J]. Hum Gene Ther,2019,30(2):236-248.
[15] Tang C,Houston BA,Storey C,et al. Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages[J]. J Lipid Res,2016,57(5):848-857.
[16] Sonett J,Goldklang M,Sklepkiewicz P,et al. A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure[J]. FASEB J,2018,32(12):fj201701381.
[17] Zhang Z,Zhai L,Lu J,et al. Shen-Hong-Tong-Luo formula attenuates macrophage inflammation and lipid accumulation through the activation of the PPAR-γ/LXR-α/ABCA1 pathway[J]. Oxid Med Cell Longev,2020,2020:3426925.
[18] Castiglioni S,Monti M,Arnaboldi L,et al. ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading[J]. Atherosclerosis,2017,266:8-15.
[19] Gu HF,Li N,Xu ZQ,et al. Chronic unpredictable mild stress promotes atherosclerosis via HMGB1/TLR4-Mediated downregulation of PPARgamma/LXRalpha/ABCA1 in ApoE(-/-) mice[J]. Front Physiol,2019,10:165.
[20] Pérez-Baos S,Barrasa JI,Gratal P,et al. Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation:understanding the lipid paradox associated with rheumatoid arthritis[J]. Br J Pharmacol,2017,174(18):3018-3031.
[21] D’Amore S,Hardfeldt J,Cariello M,et al. Identification of miR-9-5p as direct regulator of ABCA1 and HDL-driven reverse cholesterol transport in circulating CD14+ cells of patients with metabolic syndrome[J]. Cardiovasc Res,2018,114(8):1154-1164.
[22] He P,Smith A,Gelissen IC,et al. The effect of statins and the synthetic LXR agonist T0901317 on expression of ABCA1 transporter protein in human lung epithelial cell lines in vitro[J]. Pharmacol Rep,2019,71(6):1219-1226.
[23] Westerterp M,Fotakis P,Ouimet M,et al. Cholesterol efflux pathways suppress inflammasome activation,NETosis,and atherogenesis[J]. Circulation,2018,138(9):898-912.
[24] Warnatsch A,Ioannou M,Wang Q,et al. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis [J]. Science,2015,349(6245):316-320.
[25] D?ring Y,Soehnlein O,Weber C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis[J]. Circ Res,2017,120(4):736-743.
[26] Kithcart AP,Libby P. Unfriendly fire from neutrophils promiscuously potentiates cardiovascular inflammation[J]. Circ Res,2017,121(9):1029-1031.
[27] Tall AR,Westerterp M. Inflammasomes, neutrophil extracellular traps,and cholesterol[J]. J Lipid Res,2019,60(4):721-727.
[28] Schumacher T,Benndorf RA. ABC transport proteins in cardiovascular disease—A brief summary[J]. Molecules,2017,22(4):589.